<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00707785</url>
  </required_header>
  <id_info>
    <org_study_id>H.22.05.12.20.A2</org_study_id>
    <secondary_id>1K01DK075478-01</secondary_id>
    <nct_id>NCT00707785</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis</brief_title>
  <official_title>Effect of Vitamin A in the Treatment of Sepsis and Necrotizing Enterocolitis in Hospitalized Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether vitamin A can improve survival and
      facilitate recovery from sepsis and necrotizing enterocolitis in hospitalized neonates.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sepsis and necrotizing enterocolitis (NEC) are leading causes of morbidity and mortality in
      neonates. Studies have shown that early reversal of the signs associated with severe disease
      is an important prognostic factor during acute illness. Vitamin A deficiency is widespread
      among children, including neonates, in developing countries. Vitamin A plays an important
      role in mediating immune responses and in maintaining epithelial integrity. For this reason
      vitamin A supplementation during the acute phase of neonatal infection could work
      synergistically with present antibiotic regimens in promoting early reversal of signs
      associated with adverse outcome and shorten the total duration of clinical illness. The
      purpose of the proposed hospital-based clinical trial is to evaluate the efficacy of vitamin
      A supplementation on reducing the morbidity and mortality among neonates hospitalized with
      sepsis (n=366) and NEC(n=150). Enrolled subjects will be randomized at the time of
      hospitalization to receive one dose of either 50,000 IU of vitamin A or placebo at
      enrollment, in addition to standard antibiotic therapy. We will compare the proportion of
      treatment failures in sepsis patients, the frequency of disease progression and mortality in
      NEC patients, and the time to clinical recovery and discharge between treatment groups. In
      addition, the study will determine whether vitamin A reduces pro-inflammatory cytokine
      levels; elevated host inflammatory cytokines are thought to contribute to the severity of
      both conditions. If vitamin A is found to be efficacious in the treatment of sepsis and NEC
      it could present a needed cost-effective approach to decreasing the global morbidity,
      mortality and the economic cost associated with neonatal sepsis and NEC in the developing
      world.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease Mortality</measure>
    <time_frame>prospective</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory cytokine concentration</measure>
    <time_frame>prospective</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of inflammation</measure>
    <time_frame>prospective</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease progression in NEC patients</measure>
    <time_frame>prospective</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Treatment failure</measure>
    <time_frame>prospective</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Time to recovery from severe illness</measure>
    <time_frame>prospective</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">424</enrollment>
  <condition>Sepsis</condition>
  <condition>Necrotizing Enterocolitis</condition>
  <condition>Meningitis</condition>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sepsis - vitamin A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sepsis - placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NEC - vitamin A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>NEC - Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin A</intervention_name>
    <description>50,000 IU of Vitamin A 50,000 IU of vegetable oil</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>Retinol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  newborns less than 29 days with clinical sepsis

        Exclusion Criteria:

          -  healthy infants

          -  major congenital abnormalities

          -  known inborn error(s) of metabolism

          -  chronic disorders of other organs (e.g. cholestasis)

          -  definite or severe NEC (&gt; stage 2)

          -  congenital heart disease

          -  Infants receiving VA supplements

          -  Infants requiring mechanical ventilation

          -  Infant is unconscious
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian L Coles, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dhaka Shishu Hospital</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2008</study_first_submitted>
  <study_first_submitted_qc>June 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2008</study_first_posted>
  <last_update_submitted>September 24, 2013</last_update_submitted>
  <last_update_submitted_qc>September 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Christian Coles</investigator_full_name>
    <investigator_title>Assistant Professor, Department of International Health</investigator_title>
  </responsible_party>
  <keyword>vitamin A</keyword>
  <keyword>Treatment</keyword>
  <keyword>neonates</keyword>
  <keyword>newborn</keyword>
  <keyword>sepsis</keyword>
  <keyword>necrotizing enterocolitis</keyword>
  <keyword>meningitis</keyword>
  <keyword>pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

